5th Annual European Microbiome Congress 13-14 Nov, London, UK
admin2019-10-09T16:32:16+01:00Building a functional understanding of the microbiome to transform drug-discovery and improve health outcomes.
Lucideon Annual Event – Advancing Formulations: The 5th Innovation for Industry Forum – 3 Oct
admin2019-09-11T16:16:24+01:00The annual event brings together industry and academia to discuss the challenges and opportunities in formulations and product development for skin, hair and oral care applications. The event covers a broad range of topics, enabling cross-sector fertilization.
Labskin Presents at the 2019 Microbiome Movement Conference on Skin Health & Dermatology
admin2019-09-12T14:46:04+01:00The 2nd annual conference of Skin health and Dermatology as part of the Microbiome Movement was held in San Diego, California in September 2019. Labskin were proud to be both a sponsor and a speaker at the event.
L’Occitane – Colonization of a 3D Skin Model
admin2019-09-06T10:17:39+01:00But most of these models are sterile. In recent years, skin microbiota has emerged as a key player in skin health, preventing pathogens proliferation, educating the immune system and maintaining barrier integrity. The first skin models colonized with bacteria have focused on unique bacterial species. But the study of skin diseases (such as atopic dermatitis) revealed that microbiota’s diversity is key to skin health. We thus developed a model that reproduces the complexity of the skin’s ecosystem with an uncultured skin microbiota and compared it to the use of a unique commensal bacteria.
Hemp and CBD Expo, 14 – 15 Sept, NEC Birmingham, UK
admin2019-09-11T16:15:57+01:00Labskin will be presenting at the second Hemp & CBD Expo at the NEC in Birmingham, UK on September 14th-15th. With specific and relevant experience in the CBD area, Labskin is proud to be a sponsor and speaker at the expo.
CBD Oil – Uses and Regulation
admin2019-08-08T16:36:51+01:00Launching a new product containing CBD Oil? In this post we outline the uses of CBD Oil, its current and future regulation and best practice for companies seeking to launch new products containing Cannabidiol (CBD).
Wound pHase CBD Infused Chronic Wound Care and Burn Products
admin2019-08-13T12:05:24+01:00Integumen today announces the expansion of its chronic wound care division, LifeScienceHub Ltd (Wound pHase), as it extends its license technology agreement (RNS 16 July 2018) with Cellulac plc (9.35% owned by Integumen).
Labskin at the Microbiome Movement Summit, 4 – 6 Sept, San Diego, CA.
admin2019-08-14T11:00:41+01:00Labskin will presenting at the Microbiome Movement’s 2nd annual conference on Skin Health and Dermatology.
How Labskin and AI is Revolutionising Healthcare and Skin Disease
admin2019-08-14T12:06:37+01:00Lab-to-Market time of skincare products, at a fraction of the cost.
New EU Device Regulations
admin2019-07-17T10:58:17+01:00On April 5th, 2017 the EU formally approved the new Medical Devices Regulation, replacing the two existing directives – the Medical Devices Directive, and the Active Implantable Medical Devices Directive.
